BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28589744)

  • 1. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
    Hu K; Callen DF; Li J; Zheng H
    Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
    Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
    Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
    Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
    Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
    Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
    Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis.
    Chen GC; Zhang ZL; Wan Z; Wang L; Weber P; Eggersdorfer M; Qin LQ; Zhang W
    Cancer Causes Control; 2015 Dec; 26(12):1719-28. PubMed ID: 26358829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
    PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
    Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
    Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.
    Kim Y; Je Y
    Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis.
    Li M; Chen P; Li J; Chu R; Xie D; Wang H
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2327-36. PubMed ID: 24780061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of 25-hydroxyvitamin D level with survival outcomes in female breast cancer patients: A meta-analysis.
    Li C; Li H; Zhong H; Li X
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105947. PubMed ID: 34214604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies.
    Wang L; Song Y; Manson JE; Pilz S; März W; Michaëlsson K; Lundqvist A; Jassal SK; Barrett-Connor E; Zhang C; Eaton CB; May HT; Anderson JL; Sesso HD
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):819-29. PubMed ID: 23149428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 25-Hydroxyvitamin D Levels and Depression in Older Adults: A Dose-Response Meta-Analysis of Prospective Cohort Studies.
    Li H; Sun D; Wang A; Pan H; Feng W; Ng CH; Ungvari GS; Tao L; Li X; Wang W; Xiang YT; Guo X
    Am J Geriatr Psychiatry; 2019 Nov; 27(11):1192-1202. PubMed ID: 31262683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose-response meta-analysis.
    Wu G; Xue M; Zhao Y; Han Y; Zhang S; Zhang J; Li C; Xu J
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32686830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
    Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
    Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal vitamin D status during pregnancy and risk of childhood asthma: A meta-analysis of prospective studies.
    Song H; Yang L; Jia C
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
    Hektoen HH; Robsahm TE; Stenehjem JS; Axcrona K; Babigumira R; Mondul AM; Gislefoss RE; Andreassen BK
    Cancer Med; 2021 Jun; 10(12):4107-4116. PubMed ID: 34080787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts.
    Visvanathan K; Mondul AM; Zeleniuch-Jacquotte A; Wang M; Gail MH; Yaun SS; Weinstein SJ; McCullough ML; Eliassen AH; Cook NR; Agnoli C; Almquist M; Black A; Buring JE; Chen C; Chen Y; Clendenen T; Dossus L; Fedirko V; Gierach GL; Giovannucci EL; Goodman GE; Goodman MT; Guénel P; Hallmans G; Hankinson SE; Horst RL; Hou T; Huang WY; Jones ME; Joshu CE; Kaaks R; Krogh V; Kühn T; Kvaskoff M; Lee IM; Mahamat-Saleh Y; Malm J; Manjer J; Maskarinec G; Millen AE; Mukhtar TK; Neuhouser ML; Robsahm TE; Schoemaker MJ; Sieri S; Sund M; Swerdlow AJ; Thomson CA; Ursin G; Wactawski-Wende J; Wang Y; Wilkens LR; Wu Y; Zoltick E; Willett WC; Smith-Warner SA; Ziegler RG
    Eur J Epidemiol; 2023 Jan; 38(1):11-29. PubMed ID: 36593337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
    Abbas S; Chang-Claude J; Linseisen J
    Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.